⌘K

Home/Filings/4/0001626659-22-000003

4//SEC Filing

HARGREAVES BRADLEY S 4

Accession 0001626659-22-000003

CIK 0001493712other

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 1:19 PM ET

Size

6.0 KB

Accession

0001626659-22-000003

Insider Transaction Report

Form 4

Period: 2022-02-04

Cell MedX Corp.cmxc

HARGREAVES BRADLEY S

DirectorVP, Technology and Operations10% Owner

Transactions

Sale
Common stock
2022-02-04$0.15/sh−7,000$1,050→ 5,482,247 total
Sale
Common stock
2022-02-07$0.18/sh−300$54→ 5,481,947 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Cell MedX Corp.

CIK 0001493712

Entity typeother

Related Parties

1

filerCIK 0001626659

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 1:19 PM ET
Size: 6.0 KB

View on SEC.gov